Entecavir (ETV) demonstrates consistent responses throughout baseline disease and demographic subgroups for the treatment of lamivudine-refractory HBeAg(+) patients with chronic hepatitis B

Yurdaydin C., Senturk H., Boron-Kaczmarska A., Raptopoulou-Gigi M., Batur Y., Goodman Z., ...More

41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 26 - 30 April 2006, vol.44 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 44
  • Doi Number: 10.1016/s0168-8278(06)80512-x
  • City: Vienna
  • Country: Austria
  • Istanbul University Affiliated: No